Congenital heart defects (CHDs) are anomalies in the heart's structure present at birth, impacting its form and function. These defects originate during fetal development, affecting components like heart valves, walls, arteries, or veins. The severity of CHDs varies, ranging from minor issues to potentially life-threatening complications. While the exact causes of most congenital heart defects remain elusive, factors such as genetic predisposition, maternal health, and environmental influences are believed to play a role. The symptoms and implications of CHDs may surface at different life stages, underscoring the importance of early detection and timely intervention. The management of congenital heart defects has witnessed remarkable progress due to advances in medical technology and surgical techniques. These developments have significantly enhanced the prognosis for individuals with CHDs, enabling many to lead fulfilling and relatively normal lives with appropriate medical care and support. Nonetheless, ongoing research efforts are essential to deepen our understanding of the intricacies surrounding congenital heart defects.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt